Antall eller omfang
There is uncertainty surrounding the number of doses as it is dependent on how many of the year in question choose to be vaccinated (vaccine coverage) and other uncertainties described below.The vaccine coverage for the HPV vaccination in girls is somewhat lower than for other vaccinations in the child vaccination programme, but it has been relatively stable/slowly increasing. The vaccine coverage that could be achieved for boys is uncertain.Norway currently has a 3 dose regime for vaccination against HPV, but the Norwegian Institute of Public Health is reviewing available documentation on a possible transition to only 2 doses. The work can result in the Norwegian vaccination programme being altered. The conclusion was not ready at the time this notice was published.This notice has a span for the number of doses per annum from 50 000 — 150 000 doses, due to the uncertainty as to whether boys will be included in the programme, the degree of vaccination coverage (particularly for boys) and whether there will be a transition from a 3 dose regime to a 2 dose regime.The contracting authority has estimated the annual need for doses can be indicated from which of the following scenarios occur in the contract period:— Vaccination of only girls, 2 doses to each girl gives a need of 50 000 doses per annum.— Vaccination of only girls, 3 doses to each girl gives a need of approx. 75 000 doses per annum.— Vaccination of girls and boys, 2 doses to each child gives a need of approx. 100 000 doses per annum.— Vaccination of girls and boys, 3 doses to each child gives a need of approx. 150 000 doses per annum.The Contracting Authority is obliged to purchase a minimum volume of 50 000 doses per annum in accordance with the contract. Call-offs in addition to the minimum volume will depend on vaccine coverage, a decision on whether boys shall be included in addition to girls and a decision on the 3 or 2 dose regime.The contracting authority is not bound by the value estimate. The calculation is based on an estimated price per dose. As a result of this, and other described uncertainties, the estimate of the procurement's value is very uncertain.See the tender documentation for further information.25 000 000180 000 000